CAN BERK LEBLEBİCİ

Yayın Ağı

Makaleler 10

1. Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols

Eren O. C., BAĞCI ÇULÇİ P., Balci S., Ohike N., Saka B., SÖKMENSÜER C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.31, ss.7001-7011, 2024 (SCI-Expanded, Scopus)

2. ASO Author Reflections: Prognostic Value of Subgrading G2 Pancreatic Neuroendocrine Tumors as 2A versus 2B

Eren O. C., BAĞCI ÇULÇİ P., Balci S., Ohike N., Saka B., SÖKMENSÜER C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.31, ss.7068-7069, 2024 (SCI-Expanded, Scopus)

3. Can endocan serve as a molecular "hepatostat" in liver regeneration?

YAZICI S. E., Gedik M. E., LEBLEBİCİ C. B., KÖSEMEHMETOĞLU K., GÜNAYDIN G., DOĞRUL A. B.

Molecular medicine (Cambridge, Mass.) , cilt.29, sa.1, ss.29, 2023 (SCI-Expanded, Scopus)

4. Infiltration pattern predicts metastasis and progression better than the T-stage and grade in pancreatic neuroendocrine tumors: a proposal for a novel infiltration-based morphologic grading

Taskin O. C., Reid M. D., Bagci P., Balci S., Armutlu A., Demirtas D., et al.

Modern Pathology , cilt.35, sa.6, ss.777-785, 2022 (SCI-Expanded, Scopus)

5. Ki67 of >=10% Identifies an Aggressive Group of PanNETs and Lends Support to Emerging Protocols in Oncology Literature Utilizing This Cut-off for Closer Follow-up and Chemotherapy Candidates

Eren O., Bagci P., Balci S., Saka B., Sokmensuer C., Leblebici C. B., et al.

MODERN PATHOLOGY , cilt.35, sa.SUPPL 2, ss.1216, 2022 (SCI-Expanded, Scopus)

6. Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma

Ismayilov R., AKTEPE O. H., Sardarova K., LEBLEBİCİ C. B., ERMAN M.

EURASIAN JOURNAL OF MEDICINE , cilt.54, sa.1, ss.77-79, 2022 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

7. Cross-sectional imaging features of unusual adrenal lesions: a radiopathological correlation

KARAOSMANOĞLU A. D., ÖNDER Ö., LEBLEBİCİ C. B., SÖKMENSÜER C., AKATA D., ÖZMEN M. N., et al.

ABDOMINAL RADIOLOGY , cilt.46, sa.8, ss.3974-3994, 2021 (SCI-Expanded, Scopus)

8. Immunoglobulin G4-related systemic disease: mesenteric and peritoneal involvement with radiopathological correlation and differential diagnoses

KARAOSMANOĞLU A. D., ÖNDER Ö., LEBLEBİCİ C. B., SÖKMENSÜER C., AKATA D., ÖZMEN M. N., et al.

ABDOMINAL RADIOLOGY , cilt.46, ss.1977-1991, 2021 (SCI-Expanded, Scopus)

9. Histopathologic Infiltration Pattern Predicts Metastasis and Progression Better than pT-Stage and Grade in Well-Differentiated Pancreatic Neuroendocrine Tumors: A Proposal for an Infiltration-Based Morphologic Grading System

Taskin O., Reid M., BAĞCI ÇULÇİ P., Balci S., Armutlu A., Demirtas D., et al.

LABORATORY INVESTIGATION , cilt.101, ss.1058-1060, 2021 (SCI-Expanded, Scopus)

10. Histopathologic Infiltration Pattern Predicts Metastasis and Progression Better than pT-Stage and Grade in Well-Differentiated Pancreatic Neuroendocrine Tumors: A Proposal for an Infiltration-Based Morphologic Grading System

Taskin O., Reid M., BAĞCI ÇULÇİ P., Balci S., Armutlu A., Demirtas D., et al.

MODERN PATHOLOGY , cilt.34, ss.1058-1060, 2021 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. Ki67 of >=10% Identifies an Aggressive Group of PanNETs and Lends Support to Emerging Protocols in Oncology Literature Utilizing This Cut-off for Closer Follow-up and Chemotherapy Candidates

Eren O., Bagci P., Balci S., Saka B., Sokmensuer C., Leblebici C. B., et al.

USCAP 111th Annual Meeting on Real Intelligence, Los-Angeles, Şili, 19 - 24 Mart 2022, cilt.102, ss.1216, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler